Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CEO, CFO, Director

Chief Medical Officer

Chief Operating Officer

Chief Financial Officer

Chief Executive Officer

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor tranexamic acid to reduce the formation of postoperative adhesions, postoperative ileus, and return of bowel function in adults. It has a license agreement with the Regents of the University of California; and co-development and distribution agreement with Newsoara Biopharma Co., Ltd. Palisade Bio, Inc. is based in Carlsbad, California.

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity o...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-06	Premium	sold (taxes)	Premium	Premium	Premium	CEO, CFO, Director
2024-05-06	Premium	acquired	Premium	Premium	Premium	CEO, CFO, Director
2024-05-06	Premium	sold (taxes)	Premium	Premium	Premium	CEO, CFO, Director
2024-05-06	Premium	acquired	Premium	Premium	Premium	CEO, CFO, Director
2024-03-11	Premium	acquired	Premium	Premium	Premium	CEO, CFO, Director
2024-02-09	Premium	acquired	Premium	Premium	Premium	-
2024-02-08	Premium	acquired	Premium	Premium	Premium	-
2024-02-08	Premium	acquired	Premium	Premium	Premium	-
2024-02-08	Premium	acquired	Premium	Premium	Premium	-
2024-02-06	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2024-02-06	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-02-06	Premium	acquired	Premium	Premium	Premium	CEO, CFO, Director
2024-02-06	Premium	bought	Premium	Premium	Premium	CEO, CFO, Director
2024-01-31	Premium	bought	Premium	Premium	Premium	CEO, CFO, Director
2024-01-31	Premium	bought	Premium	Premium	Premium	-
2024-01-03	Premium	acquired	Premium	Premium	Premium	CEO, CFO, Director
2023-12-11	Premium	acquired	Premium	Premium	Premium	CEO, CFO, Director
2023-11-20	Premium	acquired	Premium	Premium	Premium	CEO, CFO, Director
2023-11-07	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2023-11-06	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-11-06	Premium	acquired	Premium	Premium	Premium	CEO, CFO, Director
2023-10-04	Premium	sold (taxes)	Premium	Premium	Premium	CEO, CFO, Director
2023-10-03	Premium	acquired	Premium	Premium	Premium	CEO, CFO, Director
2023-09-27	Premium	bought	Premium	Premium	Premium	-
2023-09-27	Premium	bought	Premium	Premium	Premium	CEO, CFO, Director

PALI - Palisade Bio, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for PALI